相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia
Ngai Cheung et al.
CANCER CELL (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors
Andrea Muscat et al.
CLINICAL CANCER RESEARCH (2016)
Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX
Kelly Marie Arcipowski et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models
Caroline Berenguer-Daize et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives
Yongcheng Song et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Divergent clonal selection dominates medulloblastoma at recurrence
A. Sorana Morrissy et al.
NATURE (2016)
Active medulloblastoma enhancers reveal subgroup-specific cellular origins
Charles Y. Lin et al.
NATURE (2016)
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
Chao Lu et al.
SCIENCE (2016)
Lack of Transcription Triggers H3K27me3 Accumulation in the Gene Body
Masaki Hosogane et al.
CELL REPORTS (2016)
Mutations in chromatin machinery and pediatric high-grade glioma
Rishi R. Lulla et al.
SCIENCE ADVANCES (2016)
Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors
Elizabeth Wadhwa et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2016)
MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin
Marco Gallo et al.
CANCER CELL (2015)
CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma
Anna M. Dahlin et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Panobinostat active against diffuse intrinsic pontine glioma
Sanjeet Bagcchi
LANCET ONCOLOGY (2015)
Epigenomics Roadmap for regulation
Casey E. Romanoski et al.
NATURE (2015)
Integrative analysis of 111 reference human epigenomes
Anshul Kundaje et al.
NATURE (2015)
Human body epigenome maps reveal noncanonical DNA methylation variation
Matthew D. Schultz et al.
NATURE (2015)
Function and information content of DNA methylation
Dirk Schuebeler
NATURE (2015)
DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia
Chun-Wei Chen et al.
NATURE MEDICINE (2015)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation
Ke Liu et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Targeting histone lysine methylation in cancer
John McGrath et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
Chiara Pastori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Epigenetic treatment of solid tumours: a review of clinical trials
Clara Nervi et al.
CLINICAL EPIGENETICS (2015)
Future clinical trials in DIPG: bringing epigenetics to the clinic
Andres Morales La Madrid et al.
FRONTIERS IN ONCOLOGY (2015)
H3K4me3 Breadth Is Linked to Cell Identity and Transcriptional Consistency
Berenice A. Benayoun et al.
CELL (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
Molecular Pathways: Deregulation of Histone H3 Lysine 27 Methylation in Cancer-Different Paths, Same Destination
Teresa Ezponda et al.
CLINICAL CANCER RESEARCH (2014)
BET bromodomain proteins are required for glioblastoma cell proliferation
Chiara Pastori et al.
EPIGENETICS (2014)
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
Volker Hovestadt et al.
NATURE (2014)
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S. C. Mack et al.
NATURE (2014)
Inhibition of demethylases by GSK-J1/J4 Reply
Laurens Kruidenier et al.
NATURE (2014)
Tyrosine phosphorylation of histone H2A by CK2 regulates transcriptional elongation
Harihar Basnet et al.
NATURE (2014)
Inhibition of demethylases by GSK-J1/J4
Bo Heinemann et al.
NATURE (2014)
Regulation of RNA polymerase II activation by histone acetylation in single living cells
Timothy J. Stasevich et al.
NATURE (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
Thomas De Raedt et al.
NATURE (2014)
ACVR1 mutations and the genomic landscape of pediatric diffuse glioma
Gelareh Zadeh et al.
NATURE GENETICS (2014)
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz et al.
NATURE GENETICS (2014)
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Adam M. Fontebasso et al.
NATURE GENETICS (2014)
An epigenetic therapy for diffuse intrinsic pontine gliomas
Vijay Ramaswamy et al.
NATURE MEDICINE (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations
G. Y. Lopez et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2014)
Epigenetic targets and drug discovery Part 1: Histone methylation
Yanli Liu et al.
PHARMACOLOGY & THERAPEUTICS (2014)
For pediatric glioma, leave no histone unturned
Oren J. Becher et al.
SCIENCE (2014)
Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling
Hans-Martin Herz et al.
SCIENCE (2014)
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation
Kosuke Funato et al.
SCIENCE (2014)
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm et al.
NATURE REVIEWS CANCER (2014)
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
Adam M. Fontebasso et al.
ACTA NEUROPATHOLOGICA (2013)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
A Tumorigenic MLL-Homeobox Network in Human Glioblastoma Stem Cells
Marco Gallo et al.
CANCER RESEARCH (2013)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
Feng Li et al.
CELL (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
Targeting histone modifications - epigenetics in cancer
Tanja Waldmann et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Kui-Ming Chan et al.
GENES & DEVELOPMENT (2013)
Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival
Christopher A. Barker et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
Olivier Mirguet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The nexus of chromatin regulation and intermediary metabolism
Philipp Gut et al.
NATURE (2013)
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Sam Behjati et al.
NATURE GENETICS (2013)
Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer
Christoph Plass et al.
NATURE REVIEWS GENETICS (2013)
Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells
Irina Alimova et al.
NEURO-ONCOLOGY (2013)
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
Sarah K. Knutson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genetics Driving Epigenetics
Terrence S. Furey et al.
SCIENCE (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
Anton Henssen et al.
ONCOTARGET (2013)
The Histone Demethylase Jarid1b Ensures Faithful Mouse Development by Protecting Developmental Genes from Aberrant H3K4me3
Mareike Albert et al.
PLOS GENETICS (2013)
Ras-Induced Changes in H3K27me3 Occur after Those in Transcriptional Activity
Masaki Hosogane et al.
PLOS GENETICS (2013)
Protein arginine methyltransferases and cancer
Yanzhong Yang et al.
NATURE REVIEWS CANCER (2013)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Fredrik J. Swartling et al.
CANCER CELL (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
J. Drappatz et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmstrom et al.
LANCET ONCOLOGY (2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick et al.
LANCET ONCOLOGY (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
Laurens Kruidenier et al.
NATURE (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
A map of the cis-regulatory sequences in the mouse genome
Yin Shen et al.
NATURE (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Sarah K. Knutson et al.
NATURE CHEMICAL BIOLOGY (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos et al.
NATURE MEDICINE (2012)
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
Bret B. Friday et al.
NEURO-ONCOLOGY (2012)
Transcriptional Architecture and Chromatin Landscape of the Core Circadian Clock in Mammals
Nobuya Koike et al.
SCIENCE (2012)
Emerging Epigenetic Targets and Therapies in Cancer Medicine
Relja Popovic et al.
CANCER DISCOVERY (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt et al.
CANCER CELL (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
ETV6 mutations in early immature human T cell leukemias
Pieter Van Vlierberghe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Mapping and analysis of chromatin state dynamics in nine human cell types
Jason Ernst et al.
NATURE (2011)
Nascent transcript sequencing visualizes transcription at nucleotide resolution
L. Stirling Churchman et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
M. Weller et al.
NEUROLOGY (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
Boris G. Wilson et al.
CANCER CELL (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Cross-species genomics matches driver mutations and cell compartments to model ependymoma
Robert A. Johnson et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Deregulation of H3K27 methylation in cancer
Eva Martinez-Garcia et al.
NATURE GENETICS (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
Zainab Jagani et al.
NATURE MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes
Zhibin Wang et al.
CELL (2009)
Histone Crosstalk between H3S10ph and H4K16ac Generates a Histone Code that Mediates Transcription Elongation
Alessio Zippo et al.
CELL (2009)
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Evanthia Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Nathaniel D. Heintzman et al.
NATURE (2009)
Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors
Elizabeth M. Algar et al.
PLOS ONE (2009)
Nucleosomal Fluctuations Govern the Transcription Dynamics of RNA Polymerase II
Courtney Hodges et al.
SCIENCE (2009)
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma
Leigh Ellis et al.
CLINICAL CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Nucleosome destabilization in the epigenetic regulation of gene expression
Steven Henikoff
NATURE REVIEWS GENETICS (2008)
Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas
Jie Li et al.
NEURO-ONCOLOGY (2008)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Advances toward an understanding of brainstem gliomas
SS Donaldson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry
JM Hilden et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
H Sawa et al.
ACTA NEUROPATHOLOGICA (2004)
Rhythmic histone acetylation underlies transcription in the mammalian circadian clock
JP Etchegaray et al.
NATURE (2003)
Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites
B Czermin et al.
CELL (2002)
Histone methyltransferase activity of a Drosophila polycomb group repressor complex
J Müller et al.
CELL (2002)
A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle
I Versteege et al.
ONCOGENE (2002)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)
分享论文
